Angion Biomedica Corp (ANGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ANGN | AZN | AMGN | GILD | VRTX |
| Company | Angion Biomedica Corp | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 1.0600 | 90.81 | 327.01 | 124.07 | 454.34 |
| High | 1.0600 | 91.86 | 331.88 | 124.90 | 460.94 |
| Low | 0.8901 | 90.63 | 326.08 | 122.84 | 453.03 |
| Latest | 1.0000 | 91.55 | 331.39 | 124.16 | 460.31 |
| Change | +0.0200 | +0.19 | +4.01 | -0.13 | +4.11 |
| % Change | +2.04% | +0.21% | +1.22% | -0.10% | +0.90% |
| Volume | 224,800 | 4,648,900 | 2,400,400 | 6,751,300 | 919,500 |
| 20-Day Average Volume | 169,795 | 5,860,990 | 3,312,010 | 7,625,010 | 1,548,690 |
| Previous Close | 0.9800 | 91.36 | 327.38 | 124.29 | 456.20 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.8324 | 91.08 | 330.18 | 122.91 | 445.00 |
| 20-Day Raw Stochastic | 72.09% | 47.94% | 55.91% | 59.42% | 91.24% |
| 20-Day Relative Strength | 67.80 | 58.16 | 55.83 | 54.03 | 61.12 |
| Weighted Alpha | +0.20 | +40.80 | +26.59 | +30.25 | +13.28 |
| Today's Opinion | 56% Buy | 100% Buy | 88% Buy | 88% Buy | 72% Buy |
| Previous Opinion | 40% Buy | 100% Buy | 72% Buy | 88% Buy | 72% Buy |
| Last Month's Opinion | 40% Sell | 100% Buy | 100% Buy | 100% Buy | 24% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +21.95% since 05/24/23 | -0.01% since 12/15/25 | +1.87% since 12/15/25 | +3.66% since 12/15/25 | +1.01% since 12/15/25 |
| Low | 0.8000 on 05/25/23 | 89.85 on 12/17/25 | 321.91 on 12/18/25 | 118.17 on 12/16/25 | 445.41 on 12/18/25 |
| High | 1.1200 on 05/31/23 | 91.87 on 12/19/25 | 331.88 on 12/22/25 | 126.27 on 12/19/25 | 460.94 on 12/22/25 |
| 1-Month | |||||
| %Chg | +49.25% since 05/01/23 | +0.60% since 11/21/25 | -1.82% since 11/21/25 | -1.96% since 11/21/25 | +7.86% since 11/21/25 |
| Low | 0.6500 on 05/02/23 | 89.28 on 12/12/25 | 312.39 on 12/11/25 | 118.17 on 12/16/25 | 423.45 on 12/01/25 |
| High | 1.1200 on 05/31/23 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.25 on 11/24/25 | 463.85 on 12/03/25 |
| 3-Month | |||||
| %Chg | +66.14% since 03/01/23 | +18.13% since 09/22/25 | +15.87% since 09/22/25 | +10.37% since 09/22/25 | +20.14% since 09/22/25 |
| Low | 0.4600 on 03/21/23 | 72.89 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 374.17 on 09/24/25 |
| High | 1.1200 on 05/31/23 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 6-Month | |||||
| %Chg | +21.95% since 12/01/22 | +30.88% since 06/20/25 | +14.54% since 06/20/25 | +14.43% since 06/20/25 | +4.41% since 06/20/25 |
| Low | 0.4600 on 03/21/23 | 68.61 on 07/21/25 | 267.83 on 06/23/25 | 104.46 on 06/25/25 | 362.50 on 08/11/25 |
| High | 1.1200 on 05/31/23 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 484.56 on 07/10/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 30,114 | 283,346,272 | 176,287,920 | 154,204,128 | 115,746,608 |
| Shares Outstanding, K | 30,114 | 3,101,426 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 2,300,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -38,810,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 0 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | -4,540,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | 0.59 | 0.32 | 0.45 | 0.32 | 0.32 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.15 on 05/10/23 | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 08/21/23 | 02/05/26 | 02/03/26 | 02/10/26 | 02/09/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 19.99 | 14.97 | 15.18 | 29.80 |